Can Fite Biopharma Ltd ADR

10-Year Study

CANF.US · Healthcare · US · Common Stock

Executive Summary: Can Fite Biopharma Ltd ADR has compounded at -53.6% annually over the last 10 years, with a maximum drawdown of 100.0% and an annualized volatility of 98.0%.

1Y CAGR
-79.7%
3Y CAGR
-63.8%
5Y CAGR
-62.8%
10Y CAGR
-53.6%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
100.0%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
-0.74
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
-1.08
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
63.4%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2018 · +-14.9%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2025 · -87.7%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
0%

Annual Returns

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
20260.318.5-34.72.95.0-7.2——————-22.3%
2025-9.218.9-15.9-26.4-0.9-2.8-36.2-6.0-1.6-32.3-16.7-42.9-87.7%
2024-4.11.43.7-6.814.09.323.6-30.4-9.57.02.3-25.9-25.9%
2023-32.1-34.5-15.5-24.048.319.0-1.6-2.6-9.9-23.415.8-6.4-63.9%
2022-9.30.95.1-25.01.1-2.1-9.813.3-18.113.0-3.4-27.4-52.7%
202110.73.621.1-12.1-0.55.6-12.3-7.0-10.8-8.4-21.17.5-27.5%
2020-34.8-41.94.838.918.1-7.921.7-7.5-20.6-2.39.8-6.3-46.1%
2019-4.8-3.3-24.6-39.4-61.4-6.20.0-14.9-15.917.546.3-6.8-82.5%
201861.0-21.1-23.4-7.6-3.9-7.7-0.89.80.4-4.78.1-5.3-14.9%
2017-24.88.9-2.1-1.0-6.31.1-1.1-5.71.2-7.7-7.83.0-37.8%
2016—————-11.0-17.818.15.6-7.6-9.18.2-17.1%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Risk Profile Insight: This asset has an estimated annualized volatility of 98.0%. The dominant macroeconomic risk driver is VTV.US, accounting for 20.8% of variance. Idiosyncratic stock-specific factors contribute 26.4%.

10-Year Historical Price Series (Growth of $10,000)
DateSimulated Value
2016-05-0110000
2016-06-018902.444845761163
2016-07-017317.073850599843
2016-08-018641.11704646381
2016-09-019128.918950089495
2016-10-018432.06456313369
2016-11-017665.509754888246
2016-12-018292.68462649961
2017-01-016236.933348710817
2017-02-016794.42522065354
2017-03-016655.055736992061
2017-04-016585.365768675018
2017-05-016167.250349042177
2017-06-016237.281781130781
2017-07-016169.337459237762
2017-08-015818.817929077975
2017-09-015888.500928746615
2017-10-015435.542267117353
2017-11-015009.060985081169
2017-12-015157.141279241755
2018-01-018302.789166678573
2018-02-016550.522526678599
2018-03-015017.41987883611
2018-04-014634.147701199688
2018-05-014454.705004918123
2018-06-014111.150638833421
2018-07-014076.6558292569644
2018-08-014475.610950115975
2018-09-014494.771248889807
2018-10-014285.715281235485
2018-11-014634.147701199688
2018-12-014390.245007224747
2019-01-014181.185555246225
2019-02-014041.812587260544
2019-03-013048.7808872274086
2019-04-011846.6918258102708
2019-05-01713.1250195267336
2019-06-01668.9902463312679
2019-07-01668.9902463312679
2019-08-01569.10628594153
2019-09-01478.5138567508375
2019-10-01562.137637542246
2019-11-01822.3005111155169
2019-12-01766.5513239212446
2020-01-01499.4198019486896
2020-02-01290.3603499701684
2020-03-01304.29764676873646
2020-04-01422.7646695565652
2020-05-01499.4198019486896
2020-06-01459.9307943527467
2020-07-01559.8147547424846
2020-08-01518.0028643467804
2020-09-01411.15025555775844
2020-10-01401.858724358713
2020-11-01441.3477319546559
2020-12-01413.47313835751976
2021-01-01457.60791155298534
2021-02-01473.86809115131484
2021-03-01573.7520515410527
2021-04-01504.0655675482123
2021-05-01501.7426847484509
2021-06-01529.6172783455871
2021-07-01464.5765599522694
2021-08-01432.0562007556106
2021-09-01385.5985447603836
2021-10-01353.07818556372473
2021-11-01278.74593597136163
2021-12-01299.65188116921377
2022-01-01271.7772875720776
2022-02-01274.10017037183894
2022-03-01288.037467170407
2022-04-01216.0281003778053
2022-05-01218.35098317756663
2022-06-01213.70521757804391
2022-07-01192.7992723801918
2022-08-01218.35098317756663
2022-09-01178.86197558162374
2022-10-01202.0908035792372
2022-11-01195.12215517995315
2022-12-01141.69585078544216
2023-01-0196.16735145455763
2023-02-0162.950124759641966
2023-03-0153.19401522842538
2023-04-0140.41815982973797
2023-05-0159.93037446162382
2023-06-0171.31250372489228
2023-07-0170.15106232501162
2023-08-0168.29275342687413
2023-09-0161.55639419367569
2023-10-0147.154519062936416
2023-11-0154.58774579439166
2023-12-0151.10342159474963
2024-01-0149.01282796107389
2024-02-0149.709691028783354
2024-03-0151.56799992692084
2024-04-0148.083675727278816
2024-05-0154.82003496047726
2024-06-0159.93037446162382
2024-07-0174.0999604262775
2024-08-0151.56799992692084
2024-09-0146.689945161312544
2024-10-0149.94198019486897
2024-11-0151.10342159474963
2024-12-0137.86298786389102
2025-01-0134.37866587952267
2025-02-0140.882738161909174
2025-03-0134.37866587952267
2025-04-0125.319421631289217
2025-05-0125.087134680477284
2025-06-0124.390269397494144
2025-07-0115.563314315346291
2025-08-0114.634162081551219
2025-09-0114.401872915465617
2025-10-019.756107315942925
2025-11-018.130089799164715
2025-12-014.6457655995226945
2026-01-014.65738027935434
2026-02-015.516846649433199
2026-03-013.600468339630088
2026-04-013.7049980656193484
2026-05-013.8908286896002564
2026-06-013.6120827536288944
Annual Return Matrix
YearAnnual Return
2017-0.37810956143660623
2018-0.14870569381216647
2019-0.8253966868227673
2020-0.4606060606060606
2021-0.2752808988764045
2022-0.5271317829457365
2023-0.639344262295082
2024-0.2590909437699751
2025-0.8773006077538523
2026-0.22250000000000003
Total Factor Risk
0.980039231011185
VTI.US Exposure
0.014894396333321748
VEA.US Exposure
0.0012095540681841222
VWO.US Exposure
-0.0007083129868584578
QQQ.US Exposure
0.13116562049406522
VTV.US Exposure
0.2080526824770902
IJR.US Exposure
0.024673776560431963
QUAL.US Exposure
-0.020888784737915115
SHV.US Exposure
0.1598948056345663
TLT.US Exposure
-0.00032121682312614595
LQD.US Exposure
0.11575074419182785
HYG.US Exposure
0.0000646739069823144
GLD.US Exposure
0.002327493356488716
USO.US Exposure
0.000584504102672003
VNQ.US Exposure
0.052357803602381355
BTC-USD.CC Exposure
0.001403018455521746
CPER.US Exposure
0.0005748139048937158
VIX.INDX Exposure
0.01064932027473114
UUP.US Exposure
0.0012035390865472906
TIP.US Exposure
0.03318015575741007
Idiosyncratic Exposure
0.26393141234078404
Value Score
43.4
Growth Score
28.4
Profit Score
12.5
Health Score
0
Yield Score
0
Moat Score
0

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
98.0%

FundamentalsiCompany financial health metrics: P/E valuation, dividend yield, Piotroski F-Score (9-point profitability signal), Altman Z-Score (bankruptcy risk proxy), and a radar chart across 6 fundamental dimensions. Note: ETFs may show N/A for some metrics.

Fundamental Dimensions

Core Valuation

P/E Ratio (TTM)P/E RatioPrice-to-Earnings ratio — the market price of a stock divided by its earnings per share, a key valuation measure.Click for full definition →N/A
Forward P/EForward P/E RatioA valuation metric that compares the current stock price to estimated future earnings per share.Click for full definition →Potentially Undervalued3.0x
Dividend YieldDividend YieldAnnual dividend paid per share divided by the current share price — expressed as a percentage income return.Click for full definition →0.00%
Squeeze RiskShort Squeeze RiskA situation where a sharp rise in the price of a stock forces short sellers to buy shares to cover their positions, further driving up the price.Click for full definition →Low
Market Cap$7.2M
Piotroski F-ScorePiotroski F-ScoreA 9-point scoring system evaluating a company's financial strength across profitability, leverage, and operating efficiency.Click for full definition →
9-point profitability signal
1.0/ 9
Weak
Altman Z-ScoreAltman Z-ScoreA bankruptcy prediction model that combines 5 financial ratios into a single score indicating financial distress risk.Click for full definition →
Bankruptcy risk proxy
-1.45
Distress Zone
Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$0
Avg Yield on Cost
0.00%

Momentum & MacroiPrice momentum indicators: distance from 50/200-Day SMA, 52-Week High proximity, Golden Cross trend signal, RSI momentum gauge, Fibonacci retracement levels, and Beta (market sensitivity).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
-2.4%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
-52.4%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
86.4% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
0.03
Market sensitivity coefficient
Trend SignalGolden Cross & Death CrossTechnical chart patterns that occur when a short-term moving average crosses over a long-term moving average.Click for full definition →
✦ Death Cross
Bearish — 50 SMA below 200 SMA
RSI (14-Day)Relative Strength Index (RSI)A momentum oscillator that measures the speed and change of price movements to identify overbought or oversold conditions.Click for full definition →
39
OversoldNeutralOverbought
Neutral
Fibonacci LevelsFibonacci RetracementTechnical levels based on mathematical ratios that indicate potential support and resistance areas.Click for full definition →
38.2% retracement-79.5%
50.0% retracement-75.8%
61.8% retracement-70.4%
% distance of current price from each 52-week Fibonacci support level.

Compare this AssetiRun a head-to-head backtest and risk analysis against similar assets.

CANF.USvsBTSG.US

Compare Can Fite Biopharma Ltd ADR vs BrightSpring Health Services, Inc. Common Stock

CANF.USvsBTSGU.US

Compare Can Fite Biopharma Ltd ADR vs BrightSpring Health Services, Inc. Tangible Equity Unit

CANF.USvsAPGE.US

Compare Can Fite Biopharma Ltd ADR vs Apogee Therapeutics, Inc. Common Stock

Frequently Asked Questions & Methodology

Is Can Fite Biopharma Ltd ADR a high-risk investment?

Can Fite Biopharma Ltd ADR (CANF.US) has an annualized volatility of 98.0% and experienced a maximum drawdown of 100.0% over the last 10 years. Its primary macro risk driver is VTV.US.

What is the 10-year return of CANF.US?

Over the past 10 years, CANF.US has generated a Compound Annual Growth Rate (CAGR) of -53.6%. It has had a positive return in 0% of the years measured.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on Can Fite Biopharma Ltd ADR

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest